Skip to main content
Premium Trial:

Request an Annual Quote

Between Two Worlds

Howard-Yana Shapiro bridges the corporate and academic worlds, writes Edward Ortiz at the Sacramento Bee. Shapiro is both chief agricultural officer at Mars, the candy company, and a senior fellow in agricultural sciences at the University of California, Davis.

Shapiro studies the genomes of plants like alfalfa, corn, and tomatoes to search for variants that confer tolerance to drought, pests, and more, and is working on how to best grow rice — not surprising, Ortiz says, as Mars owns the Uncle Ben's brand.

He's also, Ortiz reports, been a key player in the sequencing and public release of the cacao genome a few years ago. Mars, a privately held company, could've kept the genome private as its intellectual property, but Shapiro tells Ortiz that the Mars family agreed with him to make the genome publicly available. He'd argued that making the genomic data available would lead to more research that would help cacao farmers and, eventually, chocolate companies.

"[Shapiro is] the kind of person that can transcend beyond the corporate world," William Guyton, president of the World Cocoa Foundation tells the Sacramento Bee. "He sees things through a lens that others in the corporate world do not."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.